BF Biosciences Limited, a Pakistani pharmaceutical company, has announced a change at the top, with founding Chief Executive Officer (CEO) Akhter Khalid Waheed set to step down on December 31, 2025, and Chief Operating Officer (COO) Muhammad Farhan Rafique appointed as the company’s new chief executive, effective January 1, 2026. The pharmaceutical disclosed the development […]